View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Illinois Tool Works Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 24 February 2026 in which we reassessed the appropriateness of the ratings in the ...

Pierre FerraguÊ
  • Pierre FerraguÊ

The Citrini report: a revival of Marxism.

The Citrini report is an interesting thought experiment. It qualifies fully as neo-marxist, calling for the tendency of profit rates to fall. Like Marx 165 years ago, the authors are nevertheless getting a couple of things wrong. Click the link below for our thoughts and our perspective on the matter.

 PRESS RELEASE

AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizati...

AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026 Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag DALLAS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- While nearly three-quarters of healthcare executives believe their own organizations will be as strong or stronger in 2026, more than half expect the healthcare industry overall to face a worse year ahead, according to a new survey of healthcare executives. The findings highlight a widening confidence gap alongside a rapi...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 25, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

SLB Ltd: 1 director

A director at SLB Ltd sold 25,000 shares at 52.000USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

International Business Machines Corp: 2 directors

Two Directors at International Business Machines Corp bought/maiden bought 484 shares at between 233.326USD and 237.829USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by a...

Wedbush Research
  • Wedbush Research
Anish Jog ... (+4)
  • Anish Jog
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig

IBM Sell-Off Unwarranted; Presents Great Buying Opportunity into 2026

Data Environments Not Getting Replaced; IBM Focused on Building Moat. IBM has been focused intently on building out its data moat through organic and inorganic verticals as the company continues to develop a moat around its data with more enterprises looking to gain more from their data. The compan

Anish Jog ... (+7)
  • Anish Jog
  • Chase Tohanczyn
  • Daniel Ives
  • Matthew Weiss
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig

Summary of Anthropic Product Event; Competition Risk to Software Overb...

Valuation Compression is Disconnected from Forward Earnings Risk. The magnitude of multiple contractions implies structural revenue impairment. Yet there is no evidence of customer churn acceleration, budget freezes, or competitive displacement in reported results The market is reacting to demo ris

Moody's Ratings says Gilead's acquisition of Arcellx improves diversit...

Moody's Ratings (Moody's) said that Gilead Sciences, Inc.'s ("Gilead"; A3 positive) acquisition of Arcellx will improve Gilead's product and therapeutic diversity through full ownership of its key cell therapy pipeline product anito-cel for multiple myeloma. Gilead announced on 23 February that it e...

 PRESS RELEASE

UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Re...

UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22 DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q4 2025% ChangeQ4 2024Full Year2025% ChangeFull Year2024Revenue$748.22%$2,730.4(...

 PRESS RELEASE

AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22 DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q4 2025% ChangeQ4 2024Full Year2025% ChangeFull Year2024Revenue$748.22%$2,730.4(8%)Gross ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Gentherm Reports 2025 Fourth Quarter and Full Year Results

Gentherm Reports 2025 Fourth Quarter and Full Year Results Achieved Record Annual Revenue of $1.5 Billion  Increased Full Year Operating Cash Flow 7% Year-over-Year; Reduced Net Leverage to 0.2x Establishes 2026 Guidance; Provides Preliminary Revenue Outlook of ~$1.7B for 2027 NOVI, Mich., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the fourth quarter and full year ended December 31, 2025. “We made significant progress on our long-...

Nisource Inc: 1 director

A director at Nisource Inc sold 12,500 shares at 45.010USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

ITW Board of Directors Declares Quarterly Dividend

ITW Board of Directors Declares Quarterly Dividend GLENVIEW, Ill., Feb. 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Illinois Tool Works Inc. (NYSE: ITW) declared a dividend on the company's common stock of $1.61 per share for the first quarter of 2026. The dividend equates to $6.44 per share on a full-year basis. The dividend will be paid on April 9, 2026 to shareholders of record as of March 31, 2026. About Illinois Tool WorksITW (NYSE: ITW) is a Fortune 300 global multi-industrial manufacturing leader with revenue of $16 billion in 2025. The company’s seven industry-leading ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch